Bg pattern

BARILUX AD 327.25 g ORAL SUSPENSION POWDER

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use BARILUX AD 327.25 g ORAL SUSPENSION POWDER

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

Barilux AD 327.25 g oral suspension powder.

Barium sulfate (DCI)

Read all of this leaflet carefully before you start taking this medicine.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you, do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any of the side effects, inform your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

Contents of the package leaflet:

  1. What Barilux AD 327.25 g is and what it is used for.
  1. Before taking Barilux AD 327.25 g.
  1. How to take Barilux AD 327.25 g.
  1. Possible side effects.
  1. Storage of Barilux AD 327.25 g.
  1. Further information.

1. What Barilux AD 327.25 g is and what it is used for

This medicinal product is for diagnostic use only.

Barilux AD belongs to a group of medicinal products known as radiological contrast media for X-rays containing barium sulfate without suspending agents, classified within the ATC (anatomical, therapeutic, and chemical classification) in the pharmacotherapeutic group VO8BA01.

Barilux AD is a radio-opaque diagnostic agent used to enhance contrast during visualization of the esophagus and gastrointestinal tract using certain radiological techniques:

  • Its oral use is indicated as a contrast medium in radiological examinations (radiographs) of the esophagus, stomach, and duodenum using the double contrast technique.

Barilux is indicated in the pediatric population for opacification of the upper and lower gastrointestinal tract only in simple contrast X-ray examinations as a diagnostic aid for pathologies in these organs.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Before taking Barilux AD 327.25 g

Do not take Barilux AD:

  • if you are allergic (hypersensitive) to the active substance or any of the other components of Barilux.
  • if you have inflammation of the abdominal cavity walls (irritated peritoneum)
  • if you have a complete obstruction of the gastrointestinal tract.
  • if you have pyloric stenosis (narrowing of the pylorus).
  • if you have or suspect you have a perforation of the gastrointestinal tract.
  • if you have postoperative gastrointestinal suture dehiscence (opening of the suture).
  • if you have a history of or suspect intestinal perforation.
  • if you have intestinal fistulas.
  • if you have tracheoesophageal or bronchoesophageal fistulas.
  • if you have had recent injuries or chemical burns in the esophagogastric tract.
  • if you have insufficient blood supply (ischemia) to the intestinal wall.
  • if you have an inflammatory disease of the intestine called "necrotizing enterocolitis"
  • if you are about to undergo gastrointestinal surgery
  • within 7 days after an endoscopic resection.
  • within 4 weeks after concurrent radiotherapy.

Special warnings and precautions for use

Particular attention should be paid when administering Barilux:

  • If you are an elderly person with diseases, mainly cardiovascular, as the examination can be stressful for you.
  • If you have high-grade stenosis (narrowing), especially distal (far) from the stomach or conditions and diseases with a high risk of perforation, such as fistulas and known gastrointestinal carcinomas, inflammatory bowel disease, diverticulitis (inflammation of a diverticulum), diverticulosis, and amebiasis (infection caused by amoebas), as in these cases, a meticulous benefit/risk assessment is necessary.

During the radiological examination, the penetration of barium sulfate into parental areas such as tissues, vascular space, and body cavities or into the respiratory tract should be prevented to avoid potentially serious adverse reactions.

You should also ensure adequate hydration after the procedure to prevent severe constipation.

To avoid potentially serious adverse reactions, during the diagnostic process, the penetration of barium sulfate into areas outside the gastrointestinal tract (parenteral) such as tissues, vascular space, and body cavities or into the respiratory tract should be prevented.

In case of massive aspiration of the product, intravasation (penetration into blood vessels), or perforation, immediate specialized medical intervention, intensive care, or even surgery may be necessary.

During the radiological examination, barium sulfate may accumulate in colon diverticula, potentially favoring and/or aggravating infectious processes at this location.

In case barium sulfate coprolites (barioliths) form due to thickening of the barium sulfate, in this case, the administration of laxatives and/or saline purgatives (with salts or minerals) is recommended.

Interaction with other medicinal products

Tell your doctor or pharmacist if you are using or have recently used other medicinal products, including those obtained without a prescription.

Certain medicinal products may interact with Barilux AD; in these cases, it may be necessary to change the dose or interrupt treatment with one of the medicinal products. It is especially important that you inform your doctor if you are using any of the following medicinal products:

  • Medicinal products that reduce intestinal peristalsis (contractions in the form of waves along the intestine): Taking these medicinal products may cause thickening of the barium sulfate suspension and increase the risk of constipation.

Pregnancy and lactation

Consult your doctor or pharmacist before using any medicinal product.

It has not been sufficiently demonstrated that the use of barium contrast media in pregnant patients is safe. Radiological examinations should not be performed in pregnant women unless strictly necessary or when the benefit to the mother outweighs the risk to the fetus. In any case, given the teratogenic effects of radiation exposure during pregnancy, regardless of the use or not of a contrast agent, the benefit of the radiological examination should be carefully assessed.

The safety of Barilux in breastfeeding women has not been investigated. Contrast media are excreted in breast milk in minimal amounts. No harm to the breastfed child is expected, and your doctor will assess the benefit/risk before performing the examination.

The use of Barilux AD is not contraindicated during breastfeeding.

Driving and using machines

Barilux AD does not affect driving or the use of tools or machines.

Important information about some of the ingredients of Barilux AD

Patients on low-sodium diets should note that this medicinal product contains 451 mg (19.6 mmol) of sodium per 340 g glass of Barilux.

This medicinal product contains sorbitol. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking/using this medicinal product.

Barilux AD may have a mild laxative effect because it contains 10.4 g of sorbitol per 340 g glass.

Caloric value: 2.6 kcal/g of sorbitol.

3. How to take Barilux AD 327.25 g

Follow the instructions for administration of Barilux AD exactly as indicated by your doctor. Consult your doctor or pharmacist if you have any doubts.

The medical staff will administer Barilux AD orally.

The doctor will determine the correct amount and administration schedule of the product required for your radiographic examination, depending on your age, weight, and the technique to be used.

In infants and children, the dose will be adjusted accordingly by the doctor based on the child's age, body weight, and the specific requirements of the pediatric radiodiagnosis.

For elderly patients, there are no special dosage recommendations.

Consult your doctor if you need clarification regarding the examination procedure. It is essential to follow your doctor's instructions once the examination is completed.

Preparation of the patient

You should drink plenty of water after the examination to reduce the risk of constipation.

Preparation of the patient for X-ray examination of the stomach:

If abundant acid secretion (stomach acidity) is observed while fasting, it is recommended, whenever possible, to aspirate the gastric secretion or perform the examination on another day (in the morning, as early as possible).

Some professionals use acid secretion inhibitors (which reduce the amount of acid produced in the stomach) before performing the X-ray examination to increase the adherence of the contrast medium to the stomach walls. The test result improves if an antispasmodic is administered additionally, either intravenously or intramuscularly, which reduces the tone of the stomach, decreases peristalsis, and delays stomach emptying.

To extend the different regions of the stomach, it is recommended to administer a medication with a carbon dioxide-forming effect simultaneously.

Preparation of the patient for pediatric use:

Newborns do not need to be fasting. For children 1-24 months, they should be fasting from 4 hours before the test, 6 hours before for children 2-4 years, and 8 hours before for children 4-14 years, although in the latter case, they may drink a little water up to 3 hours before the study.

In small children, it is recommended not to provide the last meal to facilitate the intake of the contrast medium.

Patients with hepatic impairment:

No dose adjustment is necessary (see section 2: Special warnings and precautions for use)

Patients with renal impairment:

No dose adjustment is necessary (see section 2: Special warnings and precautions for use)

If you use more Barilux AD than you should

Rarely, repeated administration of barium sulfate suspensions may cause stomach spasms and diarrhea. These reactions are transient and not considered serious.

In examinations where high doses of barium enema are administered, an alteration of the electrolyte balance in the blood serum may occur due to the large amount of water retained by the contrast medium. In such cases, the risk can be reduced by adding sodium chloride to the enema liquid. The electrolyte balance in the serum is restored through adequate infusion therapy.

In case of overdose or accidental ingestion, consult the Toxicological Information Service. Telephone 91.562.04.20.

If you forget to take Barilux AD

Do not take a double dose to make up for forgotten doses.

If you stop taking Barilux AD

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicinal products, Barilux AD can cause side effects, although not everybody gets them.

Serious adverse reactions, reported with the administration of barium sulfate formulations, are generally associated with a defective administration technique or pre-existing pathological conditions.

If you experience any of the side effects, inform your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

Rare side effects(it is likely that they will affect between 1 and 10 in every 10,000 people)

  • allergic reactions (urticaria, anaphylactic shock, skin rashes).

Very rare side effects(it is likely that they will affect less than 1 in every 10,000 people)

  • intravasation and embolization of barium.
  • formation of bariolites that can cause blockage of the large intestine.

Side effects of unknown frequency

  • Aspiration pneumonitis.
  • Increased or intensified intestinal obstruction.

5. Storage of Barilux AD 327.25 g

This medicinal product does not require any special storage temperature.

Keep the container in the original packaging to protect it from moisture.

Keep out of the reach and sight of children.

Do not use Barilux AD after the expiry date stated on the container. The expiry date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Further information

Composition of Barilux AD

  • The active substance is barium sulfate. 100 g of powder for suspension contain 96.25 g of barium sulfate.
  • 1 single-dose glass of 340 g of powder for suspension contains 327.25 g of barium sulfate
  • The other ingredients are: sorbitol, sodium citrate, dimethicone, sodium saccharin, 3-ethoxy-4-hydroxybenzaldehyde; ethyl vanillin; polysorbate 20.

Appearance of the product and packaging contents

Barilux AD is available in clinical packaging containing 23 single-dose glasses of 340 g of powder for oral suspension each.

Marketing authorization holder and manufacturer

Marketing authorization holder:

Iberoinvesa Pharma S.L. Calle Zurbarán 18, 6º. 28010. Madrid. Spain.

Manufacturer:

Sanochemia Pharmazeutika AG. Landegger Str. 7. A-2491 Neufeld/Leitha. Austria.

This leaflet was approved in December 2010.

Online doctors for BARILUX AD 327.25 g ORAL SUSPENSION POWDER

Discuss questions about BARILUX AD 327.25 g ORAL SUSPENSION POWDER, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (1164)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Camera Book a video appointment
€87
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (191)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€60
0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

Camera Book a video appointment
€55

Get BARILUX AD 327.25 g ORAL SUSPENSION POWDER Prescription Online

1

Fill in a 2-min form

Tell us your symptoms, history, and what medicine you're requesting.

2

Pick a doctor or let us assign

Choose a specialist or we'll match you with the next available doctor.

3

Doctor reviews your case

Usually within 30 minutes. They may ask follow-up questions via chat.

4

Collect from any pharmacy

Electronic prescription sent to your email — valid across Spain.

Frequently Asked Questions

Is a prescription required for BARILUX AD 327.25 g ORAL SUSPENSION POWDER?
BARILUX AD 327.25 g ORAL SUSPENSION POWDER requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in BARILUX AD 327.25 g ORAL SUSPENSION POWDER?
The active ingredient in BARILUX AD 327.25 g ORAL SUSPENSION POWDER is barium sulfate with suspending agents. This information helps identify medicines with the same composition but different brand names.
Who manufactures BARILUX AD 327.25 g ORAL SUSPENSION POWDER?
BARILUX AD 327.25 g ORAL SUSPENSION POWDER is manufactured by Iberoinvesa Pharma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of BARILUX AD 327.25 g ORAL SUSPENSION POWDER online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether BARILUX AD 327.25 g ORAL SUSPENSION POWDER is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to BARILUX AD 327.25 g ORAL SUSPENSION POWDER?
Other medicines with the same active substance (barium sulfate with suspending agents) include BARIGRAF 555.2 g POWDER FOR RECTAL SUSPENSION, BARIGRAF AD 333.2 g ORAL SUSPENSION POWDER, BARIGRAF TAC POWDER FOR ORAL SUSPENSION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media